Contract DOCSB134108SU0910
Solomon Park Research Laboratories, Inc · Department Of Commerce · September 13, 2008
Solomon Park Research Laboratories, Inc was awarded a federal contract by Department Of Commerce (National Institute Of Standards And Technology) on September 13, 2008 for $46,000 of work in biological product (except diagnostic) manufacturing. Performance is in Kirkland, WA. It was awarded under full and open competition. The contract has been modified 1 time since the base award It uses firm fixed-price contract pricing. The most recent modification was on July 10, 2014.
Contract details
- PIID
- DOCSB134108SU0910
- Award type
- Po
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Not Competed
- NAICS
- 325414 · Biological Product (Except Diagnostic) Manufacturing
- Product / service
- Drugs And Biologicals
- Place of performance
- Kirkland, WA
- First action
- September 13, 2008
- Latest action
- July 10, 2014
Description
RECORD CORRECTED ON 3/21/2017 TO REFLECT CONTRACT CLOSEOUT.
Modification timeline
-
July 10, 2014Mod 1$0
-
September 13, 2008Base awardSRM 967A- FROZEN HUMAN SERUM$45.6K
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Illumina, Inc. | Department Of Commerce | September 19, 2025 | $46.6K |
| American Type Culture Collection | Department Of Commerce | September 19, 2025 | $338.2K |
| Solomon Park Research Laboratories, Inc | Department Of Commerce | September 3, 2025 | $273.7K |
| Eurofins Lancaster Laboratories Llc | Department Of Commerce | June 28, 2024 | $349.6K |
| Mckesson Medical-Surgical Government Solutions Llc | Department Of Commerce | September 15, 2021 | $4.1K |
| Promega Corporation | Department Of Commerce | August 12, 2011 | $15.9K |
Top contractors in NAICS 325414
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Pfizer Inc | 3 | $15.27B |
| 2 | Sanofi Vaccines Us Inc. | 606 | $9.38B |
| 3 | Regeneron Pharmaceuticals Inc | 1 | $5.57B |
| 4 | Merck Sharp & Dohme Corp. | 56 | $3.99B |
| 5 | Emergent Biodefense Operations Lansing Llc | 16 | $3.34B |
| 6 | Merck Sharp & Dohme Llc | 15 | $3.33B |
| 7 | Pfizer Inc. | 25 | $3.11B |
| 8 | Glaxosmithkline Holdings (Americas) Inc. | 109 | $2.24B |
| 9 | Modernatx, Inc. | 1 | $1.75B |
| 10 | Bavarian Nordic A/S | 1 | $1.01B |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract DOCSB134108SU0910?
Contract DOCSB134108SU0910 is a federal contract awarded to Solomon Park Research Laboratories, Inc by Department Of Commerce on September 13, 2008 for $46,000 of work classified under BIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING. It has been modified 1 time since the base award.
Who won contract DOCSB134108SU0910?
Solomon Park Research Laboratories, Inc won contract DOCSB134108SU0910 from Department Of Commerce.
How much is contract DOCSB134108SU0910 worth?
Contract DOCSB134108SU0910 has obligated $46,000 to date.